510(k) K122304

Device
HUMAN C1 INACTIVATOR KIT FOR USE ON SPAPLUS
Applicant
THE BINDING SITE GROUP, LTD.
510(k) number
K122304
Product code
DBA  
Decision
Substantially Equivalent (SESE)
Decision date
2013-04-15
Date received
2012-08-01
Regulation
866.5250
Classification name
Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Traditional
Statement or summary
Statement
Third party reviewed
No

Applicant Contact#

Contact
JILL CONSTANTINE
Address
8 Calthorpe Rd. Birmingham GB B15 1QT B15 1QT

FDA Registration Numbers#

Source Documents#

510(k) summary PDF not indicated by FDA

Other 510(k) Records For Product Code DBA  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K141100OPTILITE C1 INACTIVATOR KITThe Binding Site Group , Ltd.2014-07-18
K072965DIMENSION VISTA C1 IN; FLEX REAGENT CARTRIDGE, CAL, CONDade Behring, Inc.2007-12-21
K011780K-ASSAY C1-INAKamiya Biomedical Co.2001-07-25
K003747C1-INHIBITOR MICROTITER ASSAY DEVICEBaxter Healthcare Corp2001-03-19
K965024N-ASSAY TIA C1-INACTIVATOR TEST KITCrestat Diagnostics, Inc.1997-07-14
K960257N ANTISERUM TO C1 INHIBITORBehring Diagnostics, Inc.1996-08-01
K951967HUMAN C1 INACTIVATOR OR C-1 ESTERASE INHIBITOR RADIAL IMMUNODIFFUSION KITKent Laboratories, Inc.1995-05-30
K915431COMPLEMENT C1 INACTIVATOR KITThe Binding Site, Ltd.1992-01-17
K872426CYTOTECH C1-INHIBITOR ENZYME IMMUNOASSAYCytotech, Inc.1987-07-23
K821898ORTHO CLASSICAL PATHWAY COMPL. TESTOrtho Diagnostic Systems, Inc.1982-07-16
K781017ANTI-HUMAN C1 INHIBITOR SERUM (GOAT)Icl Scientific1978-08-14
K780335LAS-R HUMAN C1 ESTERASE INHIBITOR TESTHyland Therapeutic Div., Travenol Laboratories1978-03-22

Legacy Summary#

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases

FDA Review#

Decision Summary